Trial intelligence / Profile preview

Refrigerated Cequa for Dry Eye Comfort

NCT05957211Completed

Sponsor
University of Waterloo
Start
May 2023
Primary completion
Feb 2024
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of cyclosporine ophthalmic solution in dry eye disease (DED), sponsored by University of Waterloo. Primary endpoint: Ocular discomfort score at 10 minutes. Started May 2023; status: completed.

02

Drugs

cyclosporine ophthalmic solution
03

Conditions

dry eye disease (DED)

Beyond the preview

Go deeper on NCT05957211.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05957211.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call